Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TTEC Holdings, Inc.TTEC · Entity 7047 | Director | May 21, 2026 | May 26, 2026 |
| UNITEDHEALTH GROUP INCUNH · Entity 2809 | CEO, Uniprise | November 07, 2006 | November 10, 2006 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TTEC Holdings, Inc.
Report date May 21, 2026 · Filed May 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 90,385 |
Reported balance
After 2026-05-21 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-21 · Exercise / conversion · Acquired 36,965 · Balance 90,385 F1: Reflects vesting of Restricted Stock Units ("RSUs") on May 21, 2026. The Reporting Person initially received 36,965 time-based RSUs on May 23, 2025. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-05-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-21 · Exercise / conversion · Disposed 36,965 · Balance 0 F1: Reflects vesting of Restricted Stock Units ("RSUs") on May 21, 2026. The Reporting Person initially received 36,965 time-based RSUs on May 23, 2025. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 70,896 |
Reported balance
After 2026-05-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-21 · Grant · Acquired 70,896 · Balance 70,896 F2: The Reporting Person received 70,896 time-based RSUs on May 21, 2026. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects vesting of Restricted Stock Units ("RSUs") on May 21, 2026. The Reporting Person initially received 36,965 time-based RSUs on May 23, 2025. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement).
F2: The Reporting Person received 70,896 time-based RSUs on May 21, 2026. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement).
UNITEDHEALTH GROUP INC
Report date November 07, 2006 · Filed November 10, 2006
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.17 · Expires 2011-01-17 | Direct | 0 |
Reported balance
After 2006-11-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2006-11-07 · Disposition to issuer · Disposed 460,000 · Balance 0 F1: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Expires 2011-01-17 | Direct | 460,000 |
Reported balance
After 2006-11-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2006-11-07 · Grant · Acquired 460,000 · Balance 460,000 F1: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.39 · Expires 2012-01-07 | Direct | 0 |
Reported balance
After 2006-11-07 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2006-11-07 · Disposition to issuer · Disposed 300,000 · Balance 0 F1: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Expires 2012-01-07 | Direct | 300,000 |
Reported balance
After 2006-11-07 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2006-11-07 · Grant · Acquired 300,000 · Balance 300,000 F1: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $20.54 · Expires 2012-08-05 | Direct | 0 |
Reported balance
After 2006-11-07 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2006-11-07 · Disposition to issuer · Disposed 200,000 · Balance 0 F1: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Expires 2012-08-05 | Direct | 200,000 |
Reported balance
After 2006-11-07 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2006-11-07 · Grant · Acquired 200,000 · Balance 200,000 F1: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.16 · Expires 2012-12-02 | Direct | 35,000 |
Reported balance
After 2006-11-07 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2006-11-07 · Disposition to issuer · Disposed 105,000 · Balance 35,000 F1: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Expires 2012-12-02 | Direct | 105,000 |
Reported balance
After 2006-11-07 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2006-11-07 · Grant · Acquired 105,000 · Balance 105,000 F1: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2)
F2: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2026 Filed May 26, 2026 20:59 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | GrantRestricted Stock Units · Derivative | 70,896 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001284939-26-000002 · form4-05262026_080504.xml · derivative · entry 3 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,896 Underlying: Common Stock · 70,896 shares Expires not disclosed F2 · security: The Reporting Person received 70,896 time-based RSUs on May 21, 2026. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F2 · derivative.exercise_date: The Reporting Person received 70,896 time-based RSUs on May 21, 2026. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F2 · derivative.expiration_date: The Reporting Person received 70,896 time-based RSUs on May 21, 2026. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 21, 2026 Filed May 26, 2026 20:59 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | Exercise / conversionRestricted Stock Units · Derivative | 36,965 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001284939-26-000002 · form4-05262026_080504.xml · derivative · entry 2 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,965 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Reflects vesting of Restricted Stock Units ("RSUs") on May 21, 2026. The Reporting Person initially received 36,965 time-based RSUs on May 23, 2025. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F1 · derivative.exercise_date: Reflects vesting of Restricted Stock Units ("RSUs") on May 21, 2026. The Reporting Person initially received 36,965 time-based RSUs on May 23, 2025. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F1 · derivative.expiration_date: Reflects vesting of Restricted Stock Units ("RSUs") on May 21, 2026. The Reporting Person initially received 36,965 time-based RSUs on May 23, 2025. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 21, 2026 Filed May 26, 2026 20:59 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | Exercise / conversionCommon Stock | 36,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001284939-26-000002 · form4-05262026_080504.xml · nonDerivative · entry 1 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,385 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Reflects vesting of Restricted Stock Units ("RSUs") on May 21, 2026. The Reporting Person initially received 36,965 time-based RSUs on May 23, 2025. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 23, 2025 Filed May 27, 2025 20:57 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | GrantRestricted Stock Units · Derivative | 36,965 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-014634 · form4-05272025_080546.xml · derivative · entry 3 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,965 Underlying: Common Stock · 36,965 shares Expires not disclosed F2 · security: The Reporting Person received 36,965 time-based RSUs on May 23,2025. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F2 · derivative.exercise_date: The Reporting Person received 36,965 time-based RSUs on May 23,2025. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F2 · derivative.expiration_date: The Reporting Person received 36,965 time-based RSUs on May 23,2025. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:57 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | Exercise / conversionRestricted Stock Units · Derivative | 29,503 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-014634 · form4-05272025_080546.xml · derivative · entry 2 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,503 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Reflects vesting of Restricted Stock Units ("RSUs") on May 22, 2025. The Reporting Person initially received 29,503 time-based RSUs on May 23, 2024. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F1 · derivative.exercise_date: Reflects vesting of Restricted Stock Units ("RSUs") on May 22, 2025. The Reporting Person initially received 29,503 time-based RSUs on May 23, 2024. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F1 · derivative.expiration_date: Reflects vesting of Restricted Stock Units ("RSUs") on May 22, 2025. The Reporting Person initially received 29,503 time-based RSUs on May 23, 2024. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:57 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | Exercise / conversionCommon Stock | 29,503 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-014634 · form4-05272025_080546.xml · nonDerivative · entry 1 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,420 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Reflects vesting of Restricted Stock Units ("RSUs") on May 22, 2025. The Reporting Person initially received 29,503 time-based RSUs on May 23, 2024. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 23, 2024 Filed May 24, 2024 20:42 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | GrantRestricted Stock Units · Derivative | 29,503 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-014531 · form4-05242024_080526.xml · derivative · entry 3 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,503 Underlying: Common Stock · 29,503 shares Expires not disclosed F2 · security: The Reporting Person received 29,503 time-based RSUs on May 23, 2024. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F2 · derivative.exercise_date: The Reporting Person received 29,503 time-based RSUs on May 23, 2024. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F2 · derivative.expiration_date: The Reporting Person received 29,503 time-based RSUs on May 23, 2024. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 22, 2024 Filed May 24, 2024 20:42 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | Exercise / conversionRestricted Stock Units · Derivative | 5,982 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-014531 · form4-05242024_080526.xml · derivative · entry 2 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,982 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Reporting Person received 5,982 time-based Restricted Stock Units ("RSUs") on May 25, 2023. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F1 · derivative.exercise_date: The Reporting Person received 5,982 time-based Restricted Stock Units ("RSUs") on May 25, 2023. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F1 · derivative.expiration_date: The Reporting Person received 5,982 time-based Restricted Stock Units ("RSUs") on May 25, 2023. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 22, 2024 Filed May 24, 2024 20:42 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | Exercise / conversionCommon Stock | 5,982 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-014531 · form4-05242024_080526.xml · nonDerivative · entry 1 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,917 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Reporting Person received 5,982 time-based Restricted Stock Units ("RSUs") on May 25, 2023. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 25, 2023 Filed May 26, 2023 20:34 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | GrantRestricted Stock Units · Derivative | 5,982 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-008855 · form4-05262023_080557.xml · derivative · entry 3 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,982 Underlying: Common Stock · 5,982 shares Expires not disclosed F2 · security: The Reporting Person received 5,982 time-based RSUs on May 25, 2023. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F2 · derivative.exercise_date: The Reporting Person received 5,982 time-based RSUs on May 25, 2023. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F2 · derivative.expiration_date: The Reporting Person received 5,982 time-based RSUs on May 25, 2023. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 24, 2023 Filed May 26, 2023 20:34 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | Exercise / conversionRestricted Stock Units · Derivative | 1,990 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-008855 · form4-05262023_080557.xml · derivative · entry 2 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,990 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Reporting Person received 1,990 time-based Restricted Stock Units ("RSUs") on May 26, 2022. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F1 · derivative.exercise_date: The Reporting Person received 1,990 time-based Restricted Stock Units ("RSUs") on May 26, 2022. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F1 · derivative.expiration_date: The Reporting Person received 1,990 time-based Restricted Stock Units ("RSUs") on May 26, 2022. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 24, 2023 Filed May 26, 2023 20:34 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | Exercise / conversionCommon Stock | 1,990 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-008855 · form4-05262023_080557.xml · nonDerivative · entry 1 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,935 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Reporting Person received 1,990 time-based Restricted Stock Units ("RSUs") on May 26, 2022. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 26, 2022 Filed May 27, 2022 21:09 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | GrantRestricted Stock Units · Derivative | 1,990 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-003174 · edgar.xml · derivative · entry 3 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,990 Underlying: Common Stock · 1,990 shares Expires not disclosed F2 · security: The Reporting Person received 1,990 time-based RSUs on May 26, 2022. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F2 · derivative.exercise_date: The Reporting Person received 1,990 time-based RSUs on May 26, 2022. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F2 · derivative.expiration_date: The Reporting Person received 1,990 time-based RSUs on May 26, 2022. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 25, 2022 Filed May 27, 2022 21:09 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | Exercise / conversionRestricted Stock Units · Derivative | 1,194 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-003174 · edgar.xml · derivative · entry 2 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,194 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Reporting Person received 1,194 time-based Restricted Stock Units ("RSUs") on May 27, 2021. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F1 · derivative.exercise_date: The Reporting Person received 1,194 time-based Restricted Stock Units ("RSUs") on May 27, 2021. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F1 · derivative.expiration_date: The Reporting Person received 1,194 time-based Restricted Stock Units ("RSUs") on May 27, 2021. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 25, 2022 Filed May 27, 2022 21:09 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | Exercise / conversionCommon Stock | 1,194 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-003174 · edgar.xml · nonDerivative · entry 1 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,945 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Reporting Person received 1,194 time-based Restricted Stock Units ("RSUs") on May 27, 2021. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 27, 2021 Filed May 28, 2021 20:43 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | GrantRestricted Stock Units · Derivative | 1,194 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006082 · edgar.xml · derivative · entry 1 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,194 Underlying: Common Stock · 1,194 shares Expires not disclosed F1 · security: The Reporting Person received 1,194 time-based Restricted Stock Units ("RSUs") on May 27, 2021. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F1 · derivative.exercise_date: The Reporting Person received 1,194 time-based Restricted Stock Units ("RSUs") on May 27, 2021. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F1 · derivative.expiration_date: The Reporting Person received 1,194 time-based Restricted Stock Units ("RSUs") on May 27, 2021. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:34 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | Exercise / conversionRestricted Stock Units · Derivative | 2,995 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-005503 · edgar.xml · derivative · entry 2 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,995 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Reporting Person received 2,995 time-based RSUs on May 14, 2020. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F1 · derivative.exercise_date: The Reporting Person received 2,995 time-based RSUs on May 14, 2020. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F1 · derivative.expiration_date: The Reporting Person received 2,995 time-based RSUs on May 14, 2020. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:34 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | Exercise / conversionCommon Stock | 2,995 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-005503 · edgar.xml · nonDerivative · entry 1 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Reporting Person received 2,995 time-based RSUs on May 14, 2020. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 14, 2020 Filed May 15, 2020 20:44 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | GrantRestricted Stock Unit · Derivative | 2,995 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-006096 · edgar.xml · derivative · entry 3 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,995 Underlying: Common Stock · 2,995 shares Expires not disclosed F2 · security: The Reporting Person received 2,995 time-based RSUs on May 14, 2020. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F2 · derivative.exercise_date: The Reporting Person received 2,995 time-based RSUs on May 14, 2020. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F2 · derivative.expiration_date: The Reporting Person received 2,995 time-based RSUs on May 14, 2020. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:44 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | Exercise / conversionRestricted Stock Units · Derivative | 3,017 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-006096 · edgar.xml · derivative · entry 2 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,017 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Reflects vesting of Restricted Stock Units ("RSUs") on May 13, 2020. The Reporting Person initially received 3,017 time-based RSUs on May 23, 2019. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F1 · derivative.exercise_date: Reflects vesting of Restricted Stock Units ("RSUs") on May 13, 2020. The Reporting Person initially received 3,017 time-based RSUs on May 23, 2019. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F1 · derivative.expiration_date: Reflects vesting of Restricted Stock Units ("RSUs") on May 13, 2020. The Reporting Person initially received 3,017 time-based RSUs on May 23, 2019. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:44 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | Exercise / conversionCommon Stock | 3,017 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-006096 · edgar.xml · nonDerivative · entry 1 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Reflects vesting of Restricted Stock Units ("RSUs") on May 13, 2020. The Reporting Person initially received 3,017 time-based RSUs on May 23, 2019. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| April 29, 2020 Filed May 1, 2020 21:18 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | SaleCommon Stock | 10,000 | $40.00 | $400,000.00 |
DisclosureSEC source: 0001179110-20-005362 · edgar.xml · nonDerivative · entry 1 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,739 F1 · security: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2020. Read SEC document |
| May 23, 2019 Filed May 24, 2019 20:35 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | GrantRestricted Stock Units · Derivative | 3,017 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-006663 · edgar.xml · derivative · entry 3 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,017 Underlying: Common Stock · 3,017 shares Expires not disclosed F2 · security: The Reporting Person received 3,017 time-based RSUs on May 23, 2019. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F2 · derivative.exercise_date: The Reporting Person received 3,017 time-based RSUs on May 23, 2019. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F2 · derivative.expiration_date: The Reporting Person received 3,017 time-based RSUs on May 23, 2019. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 22, 2019 Filed May 24, 2019 20:35 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | Exercise / conversionRestricted Stock Units · Derivative | 2,793 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-006663 · edgar.xml · derivative · entry 2 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,793 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Reflects vesting of Restricted Stock Units ("RSUs") on May 22, 2019. The Reporting Person initially received 2,793 time-based RSUs on May 24, 2018. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F1 · derivative.exercise_date: Reflects vesting of Restricted Stock Units ("RSUs") on May 22, 2019. The Reporting Person initially received 2,793 time-based RSUs on May 24, 2018. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F1 · derivative.expiration_date: Reflects vesting of Restricted Stock Units ("RSUs") on May 22, 2019. The Reporting Person initially received 2,793 time-based RSUs on May 24, 2018. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 22, 2019 Filed May 24, 2019 20:35 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | Exercise / conversionCommon Stock | 2,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-006663 · edgar.xml · nonDerivative · entry 1 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,739 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Reflects vesting of Restricted Stock Units ("RSUs") on May 22, 2019. The Reporting Person initially received 2,793 time-based RSUs on May 24, 2018. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 24, 2018 Filed May 25, 2018 20:32 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | GrantRestricted Stock Units · Derivative | 2,793 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-007567 · edgar.xml · derivative · entry 3 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,793 Underlying: Common Stock · 2,793 shares Expires not disclosed F2 · security: The Reporting Person received 2,793 time-based RSUs on May 24, 2018. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F2 · derivative.exercise_date: The Reporting Person received 2,793 time-based RSUs on May 24, 2018. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F2 · derivative.expiration_date: The Reporting Person received 2,793 time-based RSUs on May 24, 2018. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 23, 2018 Filed May 25, 2018 20:32 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | Exercise / conversionRestricted Stock Units · Derivative | 2,398 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-007567 · edgar.xml · derivative · entry 2 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,398 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Reflects vesting of Restricted Stock Units ("RSUs") on May 23, 2018. The Reporting Person initially received 2,398 time-based RSUs on May 25, 2017. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F1 · derivative.exercise_date: Reflects vesting of Restricted Stock Units ("RSUs") on May 23, 2018. The Reporting Person initially received 2,398 time-based RSUs on May 25, 2017. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F1 · derivative.expiration_date: Reflects vesting of Restricted Stock Units ("RSUs") on May 23, 2018. The Reporting Person initially received 2,398 time-based RSUs on May 25, 2017. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 23, 2018 Filed May 25, 2018 20:32 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | Exercise / conversionCommon Stock | 2,398 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-007567 · edgar.xml · nonDerivative · entry 1 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,946 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Reflects vesting of Restricted Stock Units ("RSUs") on May 23, 2018. The Reporting Person initially received 2,398 time-based RSUs on May 25, 2017. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 25, 2017 Filed May 26, 2017 20:34 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | GrantRestricted Stock Units · Derivative | 2,398 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-008107 · edgar.xml · derivative · entry 3 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,398 Underlying: Common Stock · 2,398 shares Expires not disclosed F2 · security: The Reporting Person received 2,398 time-based RSUs on May 25, 2017. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F2 · derivative.exercise_date: The Reporting Person received 2,398 time-based RSUs on May 25, 2017. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F2 · derivative.expiration_date: The Reporting Person received 2,398 time-based RSUs on May 25, 2017. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 24, 2017 Filed May 26, 2017 20:34 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | Exercise / conversionRestricted Stock Units · Derivative | 3,721 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-008107 · edgar.xml · derivative · entry 2 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,721 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Reflects vesting of Restricted Stock Units ("RSUs") on May 24, 2017. The Reporting Person initially received 3,721 time-based RSUs on May 26, 2016. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F1 · derivative.exercise_date: Reflects vesting of Restricted Stock Units ("RSUs") on May 24, 2017. The Reporting Person initially received 3,721 time-based RSUs on May 26, 2016. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). F1 · derivative.expiration_date: Reflects vesting of Restricted Stock Units ("RSUs") on May 24, 2017. The Reporting Person initially received 3,721 time-based RSUs on May 26, 2016. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| May 24, 2017 Filed May 26, 2017 20:34 UTC | TTEC Holdings, Inc. TTEC · Entity 7047 | Exercise / conversionCommon Stock | 3,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-008107 · edgar.xml · nonDerivative · entry 1 BAHL TRACY L · CIK 0001284939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,548 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Reflects vesting of Restricted Stock Units ("RSUs") on May 24, 2017. The Reporting Person initially received 3,721 time-based RSUs on May 26, 2016. The RSUs vest in full on the earlier of: (i) the first anniversary of the date of the grant; (ii) the date of the succeeding year's annual meeting of stockholders; or (iii) any change-in-control event (as defined in the RSU Agreement). Read SEC document |
| November 07, 2006 Filed Nov 10, 2006 01:45 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 105,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001181431-06-062880 · rrd135930.xml · derivative · entry 8 BAHL TRACY L · CIK 0001284939 · CEO, Uniprise 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires 2012-12-02 F1 · derivative.exercise_price: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · derivative.exercise_price: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · kind: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · price: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · derivative.exercise_date: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| November 07, 2006 Filed Nov 10, 2006 01:45 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 105,000 | Not disclosed Strike: $19.16 | Not disclosed |
DisclosureSEC source: 0001181431-06-062880 · rrd135930.xml · derivative · entry 7 BAHL TRACY L · CIK 0001284939 · CEO, Uniprise 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 105,000 shares Expires 2012-12-02 F1 · kind: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · kind: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · price: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · derivative.exercise_date: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| November 07, 2006 Filed Nov 10, 2006 01:45 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 200,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001181431-06-062880 · rrd135930.xml · derivative · entry 6 BAHL TRACY L · CIK 0001284939 · CEO, Uniprise 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2012-08-05 F1 · derivative.exercise_price: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · derivative.exercise_price: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · kind: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · price: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · derivative.exercise_date: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| November 07, 2006 Filed Nov 10, 2006 01:45 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 200,000 | Not disclosed Strike: $20.54 | Not disclosed |
DisclosureSEC source: 0001181431-06-062880 · rrd135930.xml · derivative · entry 5 BAHL TRACY L · CIK 0001284939 · CEO, Uniprise 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 200,000 shares Expires 2012-08-05 F1 · kind: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · kind: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · price: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · derivative.exercise_date: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| November 07, 2006 Filed Nov 10, 2006 01:45 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 300,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001181431-06-062880 · rrd135930.xml · derivative · entry 4 BAHL TRACY L · CIK 0001284939 · CEO, Uniprise 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2012-01-07 F1 · derivative.exercise_price: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · derivative.exercise_price: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · kind: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · price: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · derivative.exercise_date: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| November 07, 2006 Filed Nov 10, 2006 01:45 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 300,000 | Not disclosed Strike: $17.39 | Not disclosed |
DisclosureSEC source: 0001181431-06-062880 · rrd135930.xml · derivative · entry 3 BAHL TRACY L · CIK 0001284939 · CEO, Uniprise 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 300,000 shares Expires 2012-01-07 F1 · kind: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · kind: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · price: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · derivative.exercise_date: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| November 07, 2006 Filed Nov 10, 2006 01:45 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 460,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001181431-06-062880 · rrd135930.xml · derivative · entry 2 BAHL TRACY L · CIK 0001284939 · CEO, Uniprise 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 460,000 Underlying: Common Stock · 460,000 shares Expires 2011-01-17 F1 · derivative.exercise_price: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · derivative.exercise_price: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · kind: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · price: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · derivative.exercise_date: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| November 07, 2006 Filed Nov 10, 2006 01:45 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 460,000 | Not disclosed Strike: $13.17 | Not disclosed |
DisclosureSEC source: 0001181431-06-062880 · rrd135930.xml · derivative · entry 1 BAHL TRACY L · CIK 0001284939 · CEO, Uniprise 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 460,000 shares Expires 2011-01-17 F1 · kind: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · kind: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · price: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options. (Continued in Footnote 2) F2 · derivative.exercise_date: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| May 02, 2006 Filed May 4, 2006 23:16 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantStock Appreciation Rights · Derivative | 125,000 | $0.00 Strike: $48.58 | $0.00 |
DisclosureSEC source: 0000731766-06-000051 · edgardoc.xml · derivative · entry 1 BAHL TRACY L · CIK 0001284939 · CEO, Uniprise, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2016-05-02 Read SEC document |
| October 31, 2005 Filed Nov 2, 2005 23:23 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $57.89 | $0.00 |
DisclosureSEC source: 0000731766-05-000123 · edgardoc.xml · derivative · entry 1 BAHL TRACY L · CIK 0001284939 · CEO, Uniprise, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2015-10-31 Read SEC document |
| May 02, 2005 Filed May 4, 2005 21:24 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $94.68 | $0.00 |
DisclosureSEC source: 0000731766-05-000067 · edgardoc.xml · derivative · entry 1 BAHL TRACY L · CIK 0001284939 · CEO, Uniprise, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2015-05-02 F1 · derivative.exercise_date: The option is exercisable in four equal annual installments beginning May 2, 2006. Read SEC document |
| March 23, 2005 Filed Feb 2, 2006 22:13 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GiftCommon Stock | 800 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-06-000016 · edgardoc.xml · nonDerivative · entry 1 BAHL TRACY L · CIK 0001284939 · CEO, Uniprise, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,230 Read SEC document |
| February 03, 2005 Filed Feb 3, 2005 21:31 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 55,000 | $0.00 Strike: $19.55 | $0.00 |
DisclosureSEC source: 0000731766-05-000026 · edgardoc.xml · derivative · entry 7 BAHL TRACY L · CIK 0001284939 · CEO, Uniprise, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 55,000 shares Expires 2010-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2005 Filed Feb 3, 2005 21:31 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | SaleCommon Stock | 55,000 | $90.03 | $4,951,606.00 |
DisclosureSEC source: 0000731766-05-000026 · edgardoc.xml · nonDerivative · entry 4 BAHL TRACY L · CIK 0001284939 · CEO, Uniprise, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,029 Read SEC document |
| February 03, 2005 Filed Feb 3, 2005 21:31 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionCommon Stock | 55,000 | $19.55 | $1,075,079.50 |
DisclosureSEC source: 0000731766-05-000026 · edgardoc.xml · nonDerivative · entry 3 BAHL TRACY L · CIK 0001284939 · CEO, Uniprise, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,029 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2005 Filed Feb 3, 2005 21:31 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $19.55 | $0.00 |
DisclosureSEC source: 0000731766-05-000026 · edgardoc.xml · derivative · entry 6 BAHL TRACY L · CIK 0001284939 · CEO, Uniprise, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 25,000 shares Expires 2010-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2005 Filed Feb 3, 2005 21:31 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | SaleCommon Stock | 25,000 | $90.00 | $2,250,000.00 |
DisclosureSEC source: 0000731766-05-000026 · edgardoc.xml · nonDerivative · entry 2 BAHL TRACY L · CIK 0001284939 · CEO, Uniprise, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,029 Read SEC document |
| February 02, 2005 Filed Feb 3, 2005 21:31 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionCommon Stock | 25,000 | $19.55 | $488,672.50 |
DisclosureSEC source: 0000731766-05-000026 · edgardoc.xml · nonDerivative · entry 1 BAHL TRACY L · CIK 0001284939 · CEO, Uniprise, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,029 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2004 Filed Dec 9, 2004 21:51 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 123,000 | $0.00 Strike: $79.70 | $0.00 |
DisclosureSEC source: 0000731766-04-000197 · edgardoc.xml · derivative · entry 1 BAHL TRACY L · CIK 0001284939 · CEO, Uniprise, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,000 Underlying: Common Stock · 123,000 shares Expires 2014-12-07 F1 · derivative.exercise_date: The option is exercisable in four equal annual installments beginning 12/7/05. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.